Micot

China
Yan’an, Shaanxi, China

Company profile

Micot company profile

Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, a biological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.

Business identity

Contact email
[email protected]
Phone number
029-89303986
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2007-01-01, Year

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
5
Total equity funding
$114.4M
Last funding
Series D / $14M / 2025-10-10
Last equity funding
Series D / $14M
Investors
8
Lead investors
4
Founders
1
Articles
6

Categories and groups

Founders and investors

Founders

Wang bing Micot

Lead investors

Chang An Hui Tong FundNorthern Light Venture CapitalNRL CapitalZSVC

Investors

Chang An Hui Tong FundDT Capital PartnersNorthern Light Venture CapitalNRL CapitalZSVC